India's Medical Device Sector Challenges Draft Bill's Pharma Alignment

India's medical device industry is raising its voice against the proposed Drugs, Medical Devices and Cosmetics Bill, 2026, arguing that the draft bill improperly categorizes medical devices alongside pharmaceutical products. Industry leaders and healthcare professionals fear that this approach could stifle innovation and deter investment in the sector.

Industry Concerns Over Regulatory Approach

Associations representing manufacturers, traders, healthcare providers, and patient advocacy groups have communicated their concerns to the Union Health Minister. These organizations assert that the draft bill's regulatory framework does not adequately consider the fundamental differences between medical devices and pharmaceuticals. They argue that the bill's current language and stipulations could undermine India's goal of becoming a global leader in medical device manufacturing.

The draft bill proposes stringent penalties, including imprisonment of up to seven years for infractions such as labeling errors and documentation lapses. Critics argue that this approach mirrors pharmaceutical regulations and is not suitable for the medical device sector, where engineering and scientific principles differ significantly from those in drug development.

Calls for a Distinct Regulatory Framework

The medical device industry has highlighted that globally, devices are regulated through risk-based assessments, quality management systems, and post-market surveillance, rather than criminal penalties. Industry representatives have pointed out that countries like the United States, Japan, and members of the European Union employ administrative enforcement rather than criminalization for regulatory compliance in the medical device sector.

The letter from industry associations, dated August 8, emphasizes that the draft bill's reliance on drug-centric terminology and punitive measures could discourage local manufacturing and innovation. It calls for a regulatory framework that acknowledges the unique nature of medical devices and supports their development and commercialization.

Implications for India's Medical Device Ambitions

The draft bill is currently under inter-ministerial review, with stakeholders from various sectors closely monitoring the discussions. The medical device industry's pushback is a critical moment in shaping how India regulates this burgeoning sector. As the government considers feedback, industry leaders hope for a revised bill that fosters growth and aligns with international best practices.

With India's medical device market poised for significant growth, the outcome of this legislative process could have far-reaching implications for both domestic manufacturers and international players looking to invest in the country.